IngentaConnect Search Results

Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations

Authors: Madkaikar, Manisha; Gupta, Maya; Jijina, Farah; Ghosh, Kanjaksha

Source: European Journal of Haematology, Volume 83, Number 6, December 2009 , pp. 503-511(9)

Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure

Authors: Sugimori, Chiharu; Mochizuki, Kanako; Qi, Zhirong; Sugimori, Naomi; Ishiyama, Ken; Kondo, Yukio; Yamazaki, Hirohito; Takami, Akiyoshi; Okumura, Hirokazu; Nakao, Shinji

Source: British Journal of Haematology, Volume 147, Number 1, October 2009 , pp. 102-112(11)

Publisher: Blackwell Publishing

Enoxaparin sodium/heparin: Thrombocytopenia and splenic rupture in a patient with paroxysmal nocturnal haemoglobinuria: case report

Source: Reactions, Volume 1, Number 1267, 2009-08-29 , pp. 15-15(1)

Publisher: Adis International

NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes

Authors: Hanaoka, Nobuyoshi; Nakakuma, Hideki; Horikawa, Kentaro; Nagakura, Shoichi; Tsuzuki, Yasuchika; Shimanuki, Masaya; Kojima, Kensuke; Yonemura, Yuji; Kawaguchi, Tatsuya

Source: British Journal of Haematology, Volume 146, Number 5, September 2009 , pp. 538-545(8)

Publisher: Blackwell Publishing

Paroxysmal nocturnal haemoglobinuria presenting as cerebral venous sinus thrombosis

Authors: Misra; Kalita; Bansal; Nair

Source: Transfusion Medicine, Volume 18, Number 5, October 2008 , pp. 308-311(4)

Publisher: Blackwell Publishing

Eculizumab in Paroxysmal Nocturnal Haemoglobinuria

Authors: Charneski, Lisa; Patel, Priti N.

Source: Drugs, Volume 68, Number 10, 2008 , pp. 1341-1346(6)

Publisher: Adis International

Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells

Authors: Szpurka, Hadrian; Schade, Andrew E.; Jankowska, Anna M.; Maciejewski, Jaroslaw P.

Source: British Journal of Haematology, Volume 142, Number 3, August 2008 , pp. 413-422(10)

Publisher: Blackwell Publishing

Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia

Authors: Yoshida, Nao; Yagasaki, Hiroshi; Takahashi, Yoshiyuki; Yamamoto, Tomoko; Liang, Juan; Wang, Yue; Tanaka, Makito; Hama, Asahito; Nishio, Nobuhiro; Kobayashi, Ryoji; Hotta, Noriko; Asami, Keiko; Kikuta, Atsushi; Fukushima, Takashi; Hirano, Naoto; Kojima, Seiji

Source: British Journal of Haematology, Volume 142, Number 3, August 2008 , pp. 427-435(9)

Publisher: Blackwell Publishing

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

Authors: Schubert, Jörg; Hillmen, Peter; Röth, Alexander; Young, Neal S.; Elebute, Modupe O.; Szer, Jeffrey; Gianfaldoni, Giacomo; Socié, Gérard; Browne, Paul; Geller, Robert; Rother, Russell P.; Muus, Petra

Source: British Journal of Haematology, Volume 142, Number 2, July 2008 , pp. 263-272(10)

Publisher: Blackwell Publishing

Antineoplastics/bisphosphonates/methylprednisolone: Severe pancytopenia associated with a paroxysmal nocturnal haemoglobinuria clone: case report

Source: Reactions, Volume 1, Number 1198, 2008-04-19 , pp. 6-7(2)

Publisher: Adis International

Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient

Authors: Kulagin, Alexander; Lisukov, Igor; Denisova, Vera; Kruchkova, Irina; Sizikova, Svetlana; Gilevich, Andrey; Pronkina, Natalia; Kozhevnikov, Vladimir; Kozlov, Vladimir

Source: British Journal of Haematology, Volume 141, Number 1, April 2008 , pp. 122-123(2)

Publisher: Blackwell Publishing

Shortened lifespan of paroxysmal nocturnal haemoglobinuria-affected RBC estimated from differences in ratios of CD59-negative populations between reticulocytes and whole RBC

Authors: NINOMIYA, H.; SATO, S.; HASEGAWA, Y.; NAGASAWA, T.

Source: International Journal of Laboratory Hematology, Volume 30, Number 1, February 2008 , pp. 41-45(5)

Publisher: Blackwell Publishing

Eculizumab reduces the risk of thromboembolism in patients with paroxysmal nocturnal haemoglobinuria

Source: Inpharma, Volume 1, Number 1621, 2008-01-19 , pp. 14-14(1)

Publisher: Adis International

Eculizumab significantly improves and stabilises kidney function in patients with paroxysmal nocturnal haemoglobinuria

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 7-7(1)

Publisher: Adis International

Eculizumab leads to results in SHEPHERD trial for PNH

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 15-15(1)

Publisher: Adis International

Purpura fulminans in paroxysmal nocturnal haemoglobinuria

Authors: Watt, Simon G.; Winhoven, Sandra; Hay, Charles R. M.; Lucas, Guy S.

Source: British Journal of Haematology, Volume 137, Number 4, May 2007 , pp. 271-271(1)

Publisher: Blackwell Publishing

Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria

Authors: Hill, Anita; Richards, Stephen J.; Hillmen, Peter

Source: British Journal of Haematology, Volume 137, Number 3, May 2007 , pp. 181-192(12)

Publisher: Blackwell Publishing

Paroxysmal Nocturnal Hemoglobinuria in Children

Author: Marry M. van den Heuvel-Eibrink,

Source: Pediatric Drugs, Volume 9, Number 1, 2007 , pp. 11-16(6)

Publisher: Adis International

Eculizumab: 5G1.1, h5G1.1, Long-Acting Anti-C5 Monoclonal Antibody 5G1-1, Long-Acting Anti-C5 Monoclonal Antibody 5G1.1

Author: Adis International Limited,

Source: Drugs in R&D, Volume 8, Number 1, 2007 , pp. 61-68(8)

Publisher: Adis International

Eculizumab for paroxysmal nocturnal haemoglobinuria

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 513, 2006-10-07 , pp. 9-9(1)

Publisher: Adis International